Sikhulile Moyo
#71,773
Most Influential Person Now
Botswanan virologist
Sikhulile Moyo's AcademicInfluence.com Rankings
Sikhulile Moyobiology Degrees
Biology
#7357
World Rank
#10266
Historical Rank
Virology
#321
World Rank
#328
Historical Rank
Download Badge
Biology
Sikhulile Moyo's Degrees
- Bachelors Microbiology University of Botswana
- Masters Virology University of Cape Town
- PhD Virology University of Cape Town
Why Is Sikhulile Moyo Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sikhulile Moyo is a Zimbabwean virologist working as the laboratory director of the Botswana–Harvard AIDS Institute Partnership and a research associate at the Harvard T.H. Chan School of Public Health. In November 2021, Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant. In 2022, Moyo was listed in the Time 100 list.
Sikhulile Moyo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (2021) (860)
- Antiretroviral regimens in pregnancy and breast-feeding in Botswana. (2010) (513)
- Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa (2022) (237)
- Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. (2016) (192)
- Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. (2011) (188)
- Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. (2019) (142)
- Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment (2015) (124)
- Higher-Than-Expected Rates of Lactic Acidosis Among Highly Active Antiretroviral Therapy-Treated Women in Botswana: Preliminary Results from a Large Randomized Clinical Trial (2007) (81)
- The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. (2007) (73)
- Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial (2017) (64)
- Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile (2019) (61)
- Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial (2009) (59)
- Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable (2016) (58)
- HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission (2010) (54)
- Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection (2011) (53)
- HIV-1 subtype C in vitro growth and coreceptor utilization. (2006) (51)
- Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana (2011) (50)
- Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C Infection (2009) (49)
- HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana (2013) (47)
- Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. (2006) (45)
- Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana (2010) (44)
- Impact of sampling density on the extent of HIV clustering. (2014) (43)
- Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action. (2012) (42)
- HIV-exposed children account for more than half of 24-month mortality in Botswana (2016) (42)
- Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. (2009) (39)
- Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. (2013) (39)
- Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor–Based HAART During Pregnancy (2011) (39)
- Implementation of the World Health Organization Regional Office for Africa Stepwise Laboratory Quality Improvement Process Towards Accreditation (2016) (38)
- Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional study (2015) (37)
- Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges (2018) (35)
- Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial. (2017) (34)
- Intra-host evolutionary rates in HIV-1C env and gag during primary infection. (2013) (34)
- Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV‐infected women in Botswana (2011) (33)
- High Viral Load and Elevated Angiogenic Markers Associated With Increased Risk of Preeclampsia Among Women Initiating Highly Active Antiretroviral Therapy in Pregnancy in the Mma Bana Study, Botswana (2013) (33)
- An Augmented SMS Intervention to Improve Access to Antenatal CD4 Testing and ART Initiation in HIV-Infected Pregnant Women: A Cluster Randomized Trial (2015) (33)
- Phylogenetic Relatedness of Circulating HIV-1C Variants in Mochudi, Botswana (2013) (32)
- Better Control of Early Viral Replication Is Associated With Slower Rate of Elicited Antiviral Antibodies in the Detuned Enzyme Immunoassay During Primary HIV-1C Infection (2009) (31)
- Identifying Recent HIV Infections: From Serological Assays to Genomics (2015) (30)
- Results of a Population-Based Survey (2016) (30)
- Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. (2011) (29)
- Timing Constraints of In Vivo Gag Mutations during Primary HIV-1 Subtype C Infection (2009) (29)
- High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana (2017) (27)
- Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, rando (2021) (27)
- Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community (2015) (26)
- Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana (2016) (25)
- Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. (2010) (25)
- Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering (2015) (24)
- Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C. (2012) (23)
- Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in Botswana (2017) (21)
- Highly Active Antiretroviral Therapy Versus Zidovudine for Prevention of Mother-to-Child Transmission in a Programmatic Setting, Botswana (2011) (21)
- Genetic and epidemiological analysis of norovirus from children with gastroenteritis in Botswana, 2013–2015 (2018) (20)
- HIV-1 Full-Genome Phylogenetics of Generalized Epidemics in Sub-Saharan Africa: Impact of Missing Nucleotide Characters in Next-Generation Sequences (2017) (20)
- Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. (2009) (20)
- Immunohaematological reference values for HIV-negative healthy adults in Botswana (2011) (19)
- Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana (2018) (19)
- An early warning system for emerging SARS-CoV-2 variants (2022) (19)
- Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life (2020) (19)
- Prevalence and Clinical Associations of CXCR4-Using HIV-1 Among Treatment-Naive Subtype C-Infected Women in Botswana (2011) (19)
- Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR (2018) (18)
- Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering. (2015) (18)
- Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana (2017) (18)
- Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015 (2018) (18)
- Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants (2016) (17)
- Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. (2014) (17)
- Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana (2015) (17)
- Phylodynamic analysis of HIV sub-epidemics in Mochudi, Botswana. (2015) (16)
- The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana (2017) (16)
- Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana (2020) (15)
- Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana (2018) (15)
- HIV-1 drug mutations in children from northern Tanzania (2014) (14)
- Training-of-trainers: A strategy to build country capacity for SLMTA expansion and sustainability (2014) (14)
- Targeted HIV testing at birth supported by low and predictable mother‐to‐child transmission risk in Botswana (2018) (14)
- Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana. (2016) (14)
- Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. (2020) (14)
- Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana (2020) (13)
- Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana (2017) (13)
- Distribution and Genetic Variability of Sapoviruses in Africa (2020) (13)
- Therapeutic Levels of Lopinavir in Late Pregnancy and Abacavir Passage into Breast Milk in the Mma Bana Study, Botswana (2013) (13)
- Undisclosed antiretroviral drug use in Botswana: implication for national estimates (2018) (13)
- Infant Feeding Practices were not Associated with Breast Milk HIV-1 RNA Levels in a Randomized Clinical Trial in Botswana (2012) (12)
- HIV/Sexually Transmitted Infection Prevalence and Sexual Behavior of Men Who Have Sex With Men in 3 Districts of Botswana: Results From the 2012 Biobehavioral Survey (2014) (12)
- Translating a National Laboratory Strategic Plan into action through SLMTA in a district hospital laboratory in Botswana (2014) (12)
- Progressing beyond SLMTA: Are internal audits and corrective action the key drivers of quality improvement? (2014) (12)
- Molecular characterization of hepatitis B virus in blood donors in Botswana (2018) (12)
- Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls (2017) (12)
- Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana (2018) (11)
- The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana (2017) (11)
- Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages (2016) (10)
- Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana. (2011) (10)
- Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana (2018) (10)
- Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis. (2016) (10)
- B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine (2018) (9)
- Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana (2016) (9)
- Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages across Villages in Botswana Treatment-as-Prevention Trial. (2020) (8)
- Phylogenetic Inference of HIV Transmission Clusters (2017) (8)
- Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples (2019) (8)
- Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana (2018) (8)
- Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana (2019) (8)
- High rates of adverse birth outcomes in HIV and syphilis co-infected women in Botswana. (2019) (8)
- HIV Exposure and Formula Feeding Predict Under‐2 Mortality in HIV‐Uninfected Children, Botswana (2018) (8)
- Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment (2020) (8)
- Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT. (2009) (8)
- HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana † (2021) (7)
- Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay (2019) (7)
- Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana (2021) (7)
- Immunohaematological reference values for HIV-negative healthy adults in Botswana (2012) (7)
- Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. (2018) (7)
- In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana (2020) (7)
- Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women (2012) (6)
- Brief Report: High Rates of Adverse Birth Outcomes in HIV and Syphilis Coinfected Women in Botswana. (2019) (6)
- No Clinically Significant Drug-Resistance Mutations in HIV-1 Subtype C–Infected Women After Discontinuation of NRTI-Based or PI-Based HAART for PMTCT in Botswana (2013) (6)
- Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana. (2020) (6)
- Vitamin D Insufficiency in HIV-infected Pregnant Women Receiving Antiretroviral Therapy is Not Associated With Morbidity, Mortality or Growth Impairment in Their Uninfected Infants in Botswana (2014) (6)
- Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana (2019) (6)
- Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection. (2011) (6)
- Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana. (2016) (5)
- Viral Reservoir in Early-Treated HIV-Infected Children and Markers for Sustained Viral Suppression. (2021) (5)
- Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among cART-Treated Adults in Botswana (2011) (5)
- Predictors of early breastfeeding cessation among HIV‐infected women in Botswana (2016) (5)
- Immune Activation Markers in Peripartum Women in Botswana: Association with Feeding Strategy and Maternal Morbidity (2014) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana (2019) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm (2018) (5)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Low rates of NRTI and NNRTI drug resistance among participants in the Botswana combination prevention program (BCPP) trial. (2019) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study (2019) (4)
- Persistence and clearance of high‐risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study (2021) (4)
- Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/ Ya Tsie trial (2021) (4)
- Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana (2021) (4)
- Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana (2020) (4)
- HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine. (2019) (3)
- Pairwise diversity and tMRCA as potential markers for HIV infection recency (2017) (3)
- Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana (2021) (3)
- High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015. (2019) (3)
- Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana (2021) (3)
- Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana (2020) (3)
- Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana (2018) (3)
- Botswana’s Progress Toward Achieving the 2020 UNAIDS 90– 90–90 Antiretroviral Treatment and Virologic Suppression Goals: Results of a Population-Based Survey (2016) (3)
- Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana (2020) (3)
- Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir‐ than with efavirenz‐based antiretroviral therapy (2021) (3)
- Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya (2022) (2)
- Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana (2018) (2)
- Afri-Can Forum 2 (2016) (2)
- HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana (2020) (2)
- Afri-Can Forum 2 (2016) (2)
- High HIV-1 RNA Among Newly Diagnosed People in Botswana. (2017) (2)
- Afri-Can Forum 2 (2016) (2)
- Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children (2022) (2)
- Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana (2021) (2)
- Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana. (2020) (2)
- Aberrant Hypermethylation of Gene Promoters ( RARB, CADM1, DAPK1 and PAX1) Is Strongly Associated with Invasive Cervical Cancer in Botswana (2020) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- A25 Impact of polymorphism in the hepatitis B surface gene on human leukocyte antigen (HLA) class II (2019) (1)
- Higher Leptin Levels are Associated with Obesity and Slower HIV Disease Progression (2017) (1)
- Dietary Fat Intake, Liver Function and Disease Progression in HIV+ Adults in Botswana, Africa (2009) (1)
- Secondary education and HIV infection in Botswana. (2016) (1)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana (2021) (1)
- Population uptake of HIV testing, treatment, viral suppression, and male circumcision in Botswana: a cluster-randomized trial (2021) (1)
- High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana. (2022) (1)
- Molecular Characterization of Sapovirus from Children with Gastroenteritis in Botswana (2022) (1)
- Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana (2022) (1)
- Human Immunodeficiency Virus Exposure but Not Early Cytomegalovirus Infection Is Associated With Increased Hospitalization and Decreased Memory T-Cell Responses to Tetanus Vaccine (2020) (1)
- Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana (2022) (1)
- Next Generation Sequencing of Near-Full Length Genome of Norovirus GII.4 from Botswana. (2021) (1)
- Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes (2019) (1)
- Immune correlates of HIV-1 reservoir cell decline in early-treated infants (2022) (1)
- Detection of inducible replication-competent HIV-1C provirus despite long-term antiretroviral treatment in perinatally infected adolescents in Botswana. (2020) (1)
- HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life. (2020) (1)
- Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination (2019) (1)
- Impact of pre-COVID-19 epidemic preparedness on the trajectory of the pandemic in African countries (2022) (1)
- No Difference in Antibody Responses to Tetanus Vaccine Among HIV-Exposed and -Unexposed Infants in Botswana (2017) (1)
- Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. (2013) (1)
- High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015. (2019) (1)
- Maternal Hepatitis B Virus Infection, Pregnancy, and Infant Health Outcomes in Botswana (2019) (0)
- Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana (2021) (0)
- Bio-Electric Impedance Analysis and Anthropometric Obesity Indices as Predictors of Dyslipidaemia Among Adults at A Tertiary Institution in Lusaka, Zambia. (2020) (0)
- Seroprevalence and risk factors of hepatitis B, C and D virus infection amongst patients with features of hepatitis in a referral hospital in Botswana: A cross-sectional study (2021) (0)
- The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes (2022) (0)
- Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial (2022) (0)
- HIV-1 drug mutations in children from northern Tanzania made this article openly available. Please share how this access benefits you. Your story matters (2014) (0)
- 2572. Decreased T-Cell Response, but Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected Infants in Botswana (2018) (0)
- 1344. Infectious Morbidity and Mortality of HIV-Exposed, Uninfected Infants Compared with HIV-Unexposed Uninfected Infants in Botswana (2022) (0)
- Selection of subcohorts. (2014) (0)
- Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross‐sectional cohort study design (2020) (0)
- Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana (2023) (0)
- Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation (2023) (0)
- Competing Risk Model for Time to Development of Tuberculosis among Adults on Combination Antiretroviral Treatment (2022) (0)
- Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial (2022) (0)
- Maternal or infant antiretroviral drugs to reduce HIV-1 transmission (2010) (0)
- Near-complete genome of SARS-CoV-2 Delta variant of concern identified in a symptomatic dog (Canis lupus familiaris) in Botswana. (2023) (0)
- Genetic diversity in L1 gene of human papillomavirus variants in individuals with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya (2021) (0)
- Decreased hepatitis B virus vaccine response among HIV-positive infants compared with HIV-negative infants in Botswana (2022) (0)
- Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana (2022) (0)
- Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study. (2016) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa. (2020) (0)
- Implementation of COVID-19 Laboratory Testing Certification Program (CoLTeP) in African Region (2022) (0)
- Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana (2020) (0)
- PO 8408 DETECTION OF EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS AMONG MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS CLINICAL ISOLATES IN BOTSWANA (2019) (0)
- P2.49 Prevalence and molecular characterisation of hepatitis b virus in blood donors in botswana (2017) (0)
- Maternal biomarkers of endothelial dysfunction and pregnancy outcomes in women with and without HIV in Botswana (2023) (0)
- High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana (2023) (0)
- Plasma Vitamin D Levels and Cardiovascular Risks in HIV+ Adults in Botswana (2011) (0)
- Molecular characterization of hepatitis B virus in blood donors in Botswana (2015) (0)
- Sub-Optimal CD4 t-Cell ReCOveRy in Hiv-1 Subtype C patientS On antiRetROviRal tHeRapy: a SeaRCH FOR pReDiCtive biOmaRkeRS anD baSeline CHaRaCteRiStiCS (2013) (0)
- Acinetobacter baumannii pneumonia epidemiology and resistance patterns in ICU patients at a Private Hospital in Gaborone, Botswana, 2011–2016 (2020) (0)
- Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment (2019) (0)
- Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana (2023) (0)
- Correction for Novitsky et al., Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering (2016) (0)
- Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum] (2021) (0)
- A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency (2018) (0)
- HIV-1C dynamics and evolutionary trends in Botswana (2016) (0)
- Changes in inflammatory marker concentrations between the third trimester and six months postpartum. (2014) (0)
- P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection (2009) (0)
- LOW FALSE RECENT RATE OF LIMITING ANTIGEN AVIDITY ASSAY COMBINED WITH HIV-1 RNA DATA IN BOTSWANA (2017) (0)
- Track B Clinical Science (2012) (0)
- PO 8481 HIGH HEPATITIS B VIRUS INCIDENCE AMONG HIV-1-INFECTED TREATMENT-NAIVE ADULTS IN BOTSWANA (2019) (0)
- HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads (2022) (0)
- Lack of HIV RNA test result is a barrier to breastfeeding among women living with HIV in Botswana (2021) (0)
- Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana (2022) (0)
- Relationship between protein intake and body composition in HIV positive adults in Botswana (2011) (0)
- A67 Use of next-generation whole-genome sequencing to understand drug-resistant Mycobacterium tuberculosis in Botswana (2018) (0)
- Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana (2014) (0)
- HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana. (2022) (0)
- GP41 DIVERSITY IN ANTIRETROVIRAL THERAPY NAïVE AND EXPERIENCED HIV-1 SUBTYPE C-INFECTED PATIENTS IN BOTSWANA: IMPLICATIONS FOR ENFUVIRTIDE (T-20) USE (2017) (0)
- 2529. Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations with 24-Month Growth and Neurodevelopment (2019) (0)
- Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status (2022) (0)
- Lower insulin sensitivity in newborns with in utero HIV and antiretroviral exposure who are uninfected in Botswana. (2022) (0)
This paper list is powered by the following services:
Other Resources About Sikhulile Moyo
What Schools Are Affiliated With Sikhulile Moyo?
Sikhulile Moyo is affiliated with the following schools:
